The United States’s track record in responding to the coronavirus pandemic has been awful. Yet the success of its vaccine development efforts shows that when it comes to biotechnology, the U.S. outpaces China and other rivals.
Latest in Biodefense
Why did problems in meat production lead the president to invoke a statute designed to preserve the nation’s security?
Lawfare’s biweekly roundup of U.S.-China technology policy and national security news.
The Lawfare Podcast Special Edition: The National Security Law Guys Talk Lt. Col. Vindman, Roger Stone and War Powers
Lawfare founder Bobby Chesney and Lawfare contributing editor Steve Vladeck host the weekly National Security Law Podcast from the University of Texas Law School, a discussion of current national security law developments. In this episode, the third edition of a Lawfare edited National Security Law Podcast, Bobby and Steve discuss a range of topics that we thought would be of interest to listeners. So we are bringing you a distilled version of their conversation.
Our favorite foreign policy nerds—with the addition of NSI Visiting Fellow Andy Keiser—discuss the geopolitics of the Coronavirus that has massively impacted China and its economy. Listen in as Jodi, Dana, Lester and Andy discuss what the Coronavirus pandemic may mean for China's place in the world, China's internal politics and the ins-and-outs of the U.S. response.
Ninety-nine years ago, on March 11, 1918, mess cook Albert Gitchell reported sick to the camp infirmary in Fort Riley, Kansas. By noon, over 100 soldiers were hospitalized. Soldiers began to die. By the end of April, two-thirds of the main Army camps were suffering from the influenza epidemic. The Spanish flu had begun its spread in the United States. The virus eventually infected an estimated 500 million people worldwide, killing somewhere between 20 and 50 million—more people than were killed in World War I. Over half of the victims were young adults.